Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether S-1 is effective in slowing tumor activity
in patients with locally advanced or metastatic pancreatic cancer who have not had
chemotherapy. The study is also looking at the safety of S-1.
Phase:
Phase 2
Details
Lead Sponsor:
Taiho Oncology, Inc.
Collaborators:
Quintiles, Inc. United BioSource Corporation United BioSource, LLC